Hypothesis: Nocturnal NAD+ levels in astrocytes set the energetic capacity for glymphatic CSF influx and lysosomal autophagy, acting as a molecular switch that decides which neural substrates are cleared versus retained each night. When NAD+ is sufficient, mitochondrial ATP production via the Sirt1/PGC-1α axis fuels AQP4‑mediated water transport and vacuolar ATPase activity, enabling robust interstitial space expansion and efficient degradation of lactate, amyloid‑β, and damaged organelles. NAD+ depletion creates an ATP bottleneck that attenuates both glymphatic flux and autophagic turnover, shifting the nightly “verdict” toward preservation of potentially maladaptive circuitry.

Mechanistic rationale:

• Glymphatic clearance requires rapid water movement through astrocytic AQP4 channels, a process driven by osmotic gradients generated by ion pumps (Na+/K+‑ATPase) that consume ATP【1】.
• Autophagic lysosomal acidification depends on V‑ATPase proton pumping, also ATP‑intensive【3】.
• NAD+ stimulates mitochondrial oxidative phosphorylation and biogenesis through Sirt1‑dependent deacetylation of PGC-1α, linking cellular redox state to ATP supply【4】【5】.
• Sleep‑associated norepinephrine low tones permit glymphatic influx, but without adequate ATP the CSF influx rate plateaus regardless of hormonal state【2】.
• Consequently, low NAD+ reduces the magnitude of interstitial space expansion (~60% increase in NREM) and slows cargo delivery to lysosomes, producing a selective clearance deficit.

Testable predictions:

1. In vivo two‑photon imaging of CSF tracer influx in mice will show a positive correlation between hippocampal astrocytic NAD+ (measured via NAD+‑specific biosensors) and glymphatic influx rate during NREM sleep.
2. Genetic astrocyte‑specific knockdown of Namnat (NAD+ synthetase) will diminish sleep‑dependent lactate clearance and amyloid‑β efflux, despite normal EEG sleep architecture and norepinephrine suppression.
3. Chronic NR (nicotinamide riboside) supplementation in aged mice will restore nocturnal ATP levels in astrocytes, rescue AQP4‑dependent water transport, and increase autophagic flux (LC3‑II/p62 ratio) during sleep, leading to reduced synaptic pruning of low‑activity spines as quantified by electron microscopy.
4. Pharmacological inhibition of Sirt1 (EX‑527) will block the NAD+‑dependent enhancement of glymphatic flux without altering basal mitochondrial respiration, demonstrating that the Sirt1/PGC‑1α axis, not merely ATP quantity, mediates the effect. Falsification: If augmenting astrocytic NAD+ fails to increase glymphatic CSF influx or autophagic markers during sleep, or if NAD+ depletion does not impair clearance when ATP is artificially supplied via permeable substrates (e.g., pyruvate), the hypothesis would be refuted.

This framework reframes sleep‑dependent brain maintenance as an NAD+‑gated energetic checkpoint, extending the “autopsy” metaphor to a metabolically regulated decision‑process that determines which neural architectures survive to the next waking state.